302 related articles for article (PubMed ID: 32213058)
1. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.
Kooyker AI; Verbeek WH; van den Berg JG; Tesselaar ME; van Leerdam ME
United European Gastroenterol J; 2020 Feb; 8(1):59-67. PubMed ID: 32213058
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
3. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
4. Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme.
Basuroy R; O'Donnell CM; Srirajaskanthan R; Ramage JK
Colorectal Dis; 2018 Apr; 20(4):O85-O91. PubMed ID: 29368418
[TBL] [Abstract][Full Text] [Related]
5. Retrograde inspection
Rath T; Pfeifer L; Neufert C; Kremer A; Leppkes M; Hoffman A; Neurath MF; Zopf S
World J Gastroenterol; 2020 Apr; 26(16):1962-1970. PubMed ID: 32390706
[TBL] [Abstract][Full Text] [Related]
6. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
[TBL] [Abstract][Full Text] [Related]
7. Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis.
Anderson R; Burr NE; Valori R
Gastroenterology; 2020 Apr; 158(5):1287-1299.e2. PubMed ID: 31926170
[TBL] [Abstract][Full Text] [Related]
8. Introduction of a colorectal cancer screening programme: results from a single-centre study.
Vermeer NCA; Bahadoer RR; Bastiaannet E; Holman FA; Meershoek-Klein Kranenbarg E; Liefers GJ; van de Velde CJH; Peeters KCMJ
Colorectal Dis; 2018 Sep; 20(9):O239-O247. PubMed ID: 29917325
[TBL] [Abstract][Full Text] [Related]
9. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
Ambe PC; Jansen S; Zirngibl H
World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
11. Adenoma and advanced neoplasia detection rates increase from 45 years of age.
Karsenti D; Tharsis G; Burtin P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Cattan P; Cavicchi M
World J Gastroenterol; 2019 Jan; 25(4):447-456. PubMed ID: 30700941
[TBL] [Abstract][Full Text] [Related]
12. [National population screening for colorectal carcinoma in the Netherlands: results of the first years since the implementation in 2014].
Elferink MAG; Toes-Zoutendijk E; Vink GR; Lansdorp-Vogelaar I; Meijer GA; Dekker E; Lemmens VEPP
Ned Tijdschr Geneeskd; 2018; 162():D2283. PubMed ID: 29519262
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Genomic Characterization of Post-Colonoscopy Colorectal Cancer.
Tanaka H; Urabe Y; Oka S; Shimohara Y; Nishimura T; Inagaki K; Okamoto Y; Matsumoto K; Yamashita K; Sumimoto K; Ninomiya Y; Yuge R; Tanaka S; Chayama K
Clin Transl Gastroenterol; 2020 Oct; 11(10):e00246. PubMed ID: 33031197
[TBL] [Abstract][Full Text] [Related]
14. Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
Bye WA; Ma C; Nguyen TM; Parker CE; Jairath V; East JE
Am J Gastroenterol; 2018 Dec; 113(12):1801-1809. PubMed ID: 30353058
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps.
Li D; Liu L; Fevrier HB; Alexeeff SE; Doherty AR; Raju M; Amsden LB; Lee JK; Levin TR; Corley DA; Herrinton LJ
Gastroenterology; 2020 Aug; 159(2):502-511.e2. PubMed ID: 32277950
[TBL] [Abstract][Full Text] [Related]
17. Management of T1 colorectal cancers detected at screening colonoscopy: A study from the French national screening programme.
Grainville T; Bretagne JF; Piette C; Rousseau C; Bordet M; Cosson M; Lièvre A
Dig Liver Dis; 2020 Aug; 52(8):909-917. PubMed ID: 32505572
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine colorectal tumors. Surgical and endoscopic treatment].
Hotz HG; Bojarski C; Buhr HJ
Chirurg; 2011 Jul; 82(7):607-11. PubMed ID: 21656304
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
20. Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center.
Silva ACB; Vicentini MFB; Mendoza EZ; Fujiki FK; da Fonseca LG; Braghiroli MIFM; Hoff PM
Curr Probl Cancer; 2019 Oct; 43(5):477-486. PubMed ID: 30826126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
